Hepatitis E
HEV test kit reagents support serological assay development for acute hepatitis E screening. The EV64 recombinant antigen is suitable for EIA and lateral-flow coating or labeling applications.
Background
The disease is mainly found in some developing countries in Asia and Africa.
Sporadic cases are prevalent in developed countries and epidemics are prevalent in developing countries.
Its epidemic characteristics resemble hepatitis a, via fecal-oral transmission.
Water epidemics are the most common, with a few food outbreaks or daily contact transmission.
Having obvious seasonality, most often after rainy season or flood;
The morbidity was mainly in young adults, and pregnant women had higher susceptibility, serious illness and high mortality.No family clustering.
Clinical Significance
Anti-heigm was detected in serum during acute phase of viral hepatitis E, which can be used as an early diagnostic index. Low titer reactance to HEIgM can be detected during the recovery period.
Product Parameters
Generally combined with HAV, high clinical positive rate of infectious disease monitoring, no problem in vaccine effect monitoring, autoimmune source.
| Material / Clone | Type | Code | Source | Application | Recommended Use |
|---|---|---|---|---|---|
| EV64 | rAg | FAHE2 | E. coli | EIA, LF | Labeling/Coating |